Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements5743Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4871Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10635 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 5743

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Ablation Treatment with FARAPULSE™ Pulsed Field Ablation (PFA) System… NCT07925359 · NAVigate-ULTRA — The Evaluation of User Experience With FARAVIEW™ Technology of… Maladie coronarienne À vérifier Non applicable NOT_YET_RECRUITING The objective of this study is to obtain experience with new and modified… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
SESAME Procedure NCT07806149 · NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective… Maladie coronarienne Traitement symptomatique Non applicable NOT_YET_RECRUITING This is an early study of a catheter-based minimally invasive procedure ca… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Topical cyanoacrylate tissue adhesive NCT07926191 · Tissue Adhesive Versus Figure-of-Eight Suture for Femoral Venous Closure After E… Maladie coronarienne Thérapie génique À vérifier NOT_YET_RECRUITING In July 2026 the electrophysiology laboratory of a Czech tertiary cardiolo… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Truvaga Plus NCT07926945 · U54: nVNS RCT — Effects of nVNS on Stress Reactivity in IBS Maladie coronarienne Traitement symptomatique Non applicable NOT_YET_RECRUITING Irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interact… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Capstan Compass Robotic System for Transcatheter Mitral Valve Replace… NCT07917208 · Early Feasibility Study of the Capstan Medical TMVR System Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This early feasibility study is evaluating the safety and performance of t… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Discontinuation of aspirin (ATC-code B01AC06 and N02BA01) NCT07854795 · RELEASE-Norway — Reconsidering Long-Term Apirin in the Elderly in Secondary Prev… Maladie coronarienne À vérifier Phase 4 NOT_YET_RECRUITING Lifelong aspirin has been a cornerstone of secondary prevention after coro… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Extracorporeal Shock Wave Therapy NCT07068399 · CSWT — Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronar… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This randomized single-blind controlled trial aims to compare the effectiv… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Modified ultrafiltration NCT00246779 · A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Su… Maladie coronarienne À vérifier Non applicable COMPLETED Cardiac surgery is a major consumer of blood products worldwide. The natur… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Naproxen NCT07549490 · Human Experimental Models of Pain (HEMP) Maladie coronarienne Immunomodulation · Traitement symptomatique Non applicable NOT_YET_RECRUITING This pilot study will test an innovative way to establish how pain medicin… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Prescription of Aspirin NCT07524335 · ASCAD-P — Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Con… Maladie coronarienne À vérifier Phase 3 RECRUITING In patients with subclinical coronary artery disease, the ASCAD-P study ai… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Pulmonary Vein Isolation NCT06402617 · RETRO-AF — Ablation of Focal Activation in Atrial Fibrillation Maladie coronarienne Ralentissement de la progression Non applicable RECRUITING Atrial Fibrillation (AF) and Heart Failure (HF) are colliding global cardi… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Serratus Posterior Superior Intercostal Plane Block With Bupivacaine NCT07588230 · Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardia… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This randomized, double-blind, placebo-controlled study aims to evaluate t… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
TAVI NCT07926022 · TAVI and PCI in Comparison to SAVR and CABG in Low and Intermediate Risk Patient… Maladie coronarienne À vérifier À vérifier RECRUITING \# WHAT IS THIS STUDY ABOUT? This study compares two different treatment a… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
This study involved an auxillary CE-marked medical device (implantabl… NCT07545512 · ODISSEY — ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Car… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING Although advances in treatment and patient management have considerably im… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Evolocumab NCT05284747 · EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Maladie coronarienne À vérifier Phase 4 ACTIVE_NOT_RECRUITING The primary objective of this study is to evaluate the effectiveness of ea… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
Microaxial flow pump (left ventricular assist device) NCT07762560 · DOUBLE-SHOCK — Routine Microaxial Heart Pump Support and Protocolized Pulmonary… Maladie coronarienne Thérapie génique Non applicable RECRUITING The goal of this clinical trial is to learn which treatment strategies imp… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
No aspirin (Prasugurel monotherapy) NCT05709626 · PREMIUM — PRasugrEl Monotherapy Following prImary percUtaneous Coronary Interven… Maladie coronarienne À vérifier Phase 4 COMPLETED The aim of this study is to evaluate the safety of prasugrel monotherapy w… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
Percutaneous Mechanical Circulatory Support NCT06445608 · PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm Maladie coronarienne À vérifier Non applicable RECRUITING This purpose of this trial is to demonstrate 30 day safety and effectivene… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
26G Needle NCT07926113 · MASS-NEEDLE — Comparison of 26G and 30G Needles for Masseter Trigger Point Injec… Myopathies Traitement symptomatique Non applicable NOT_YET_RECRUITING This randomized split-face study aims to compare the effects of 26G and 30… À vérifier ClinicalTrials.gov 2026-11-09 21:02:59 Détail
ABSK021 NCT04192344 · A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in… Myopathies À vérifier Phase 1 RECRUITING This is an open-label phase 1 study to determine the safety and tolebility… À vérifier ClinicalTrials.gov 2026-11-09 21:02:59 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4871

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Assessing the effect of tDCS on inhibitory capacity: A pre-registered… Sham tDCS · PMID 42275807 Maladie de Parkinson · Sclérose en plaques · Maladie de Parkinson À vérifier Publication PubMed Voir la publication source Transcranial direct current stimulation (tDCS) is a promising tool for experimental and rehabilitation purposes, but it… Cortex; a journal devoted to the study of the nervous… 2026-08-16 13:06:08 Source
Dissociable roles of frontal electroencephalography markers in depres… active tDCS · PMID 42341411 Maladie de Parkinson Traitement symptomatique Publication PubMed Voir la publication source Transcranial direct current stimulation (tDCS) is a promising intervention for major depressive disorder; however, elec… Journal of psychiatric research 2026-08-16 13:06:07 Source
A wax-printed Janus paper-based microfluidic wearable sensor for meta… Sorbitol · PMID 42224781 Maladie d’Alzheimer · Maladie de Parkinson À vérifier Publication PubMed Voir la publication source Wearable sweat sensors enable noninvasive, real-time biochemical monitoring, holding significant potential for personal… Biosensors & bioelectronics 2026-08-16 13:06:03 Source
Glycohypoxia: a hypothesis linking chronic hyperglycemia to functiona… Sorbitol · PMID 41830794 Cancer Remyélinisation indirecte / réparation · Immunomodulation Publication PubMed Voir la publication source FactsHbA1c formation increases hemoglobin oxygen affinity, inducing functional hypoxia despite normal oxygenation. Osmo… Medical gas research 2026-08-16 13:06:03 Source
Hydrogen supplementation improves glucose-based n-caproate production… Metabolic Cofactor Supplementation · PMID 42250817 Maladie d’Alzheimer · Maladie de Parkinson · Maladie de Parkinson Thérapie génique Publication PubMed Voir la publication source Medium-chain carboxylic acids, such as n-caproate, are attractive sustainable platform chemicals. However, their microb… Bioresource technology 2026-08-16 13:06:03 Source
Multi-walled carbon nanotube buckypaper with covalently bound NAD and… Metabolic Cofactor Supplementation · PMID 42035674 Maladie d’Alzheimer · Maladie de Parkinson · Maladie de Parkinson À vérifier Publication PubMed Voir la publication source We report a novel bioelectrode architecture for glucose detection, integrating multi-walled carbon nanotube buckypaper… Talanta 2026-08-16 13:06:03 Source
Pharmaceutical development of composition of effervescent tablets wit… Sorbitol · PMID 42165041 Maladie d’Alzheimer · Maladie de Parkinson Thérapie génique Publication PubMed Voir la publication source This study aims to develop and optimize a stable composition of effervescent tablets containing acetylsalicylic acid (3… Pharmaceutical science advances 2026-08-16 13:06:03 Source
UHPLC-Q-Exactive Orbitrap MS-based brain-gut metabolomics implicates… Metabolic Cofactor Supplementation · PMID 42284918 Maladie d’Alzheimer · Maladie de Parkinson · Maladie de Parkinson Neuroprotection · Immunomodulation · Traitement symptomatique Publication PubMed Voir la publication source Ginseng stem-leaf saponins (GSLS) were evaluated as potential bioactive food ingredients by characterizing brain-gut me… Journal of pharmaceutical and biomedical analysis 2026-08-16 13:06:03 Source
Causal Mediation Analysis of Factors Influencing Physical Activity an… Pathways Mediating Impaired Postural Control in Parkinson's Disease · PMID 39505247 Maladie de Parkinson Traitement symptomatique Publication PubMed Voir la publication source To examine how known causal factors (exercise self-efficacy, balance, walking capacity) affect outcomes (moderate-inten… Archives of physical medicine and rehabilitation 2026-08-16 13:06:01 Source
Bevacizumab induces apoptosis in glioblastoma cells by upregulating m… Bevacizumab · PMID 42133791 Cancer · Maladie de Parkinson · Cancer Thérapie génique Publication PubMed Voir la publication source We sought to determine the pro-apoptotic effects of bevacizumab in glioblastoma (GBM) and to elucidate the contribution… RNA biology 2026-08-16 13:06:00 Source
Cost-effectiveness of finotonlimab plus bevacizumab versus sorafenib… Bevacizumab · PMID 42505057 Cancer · Maladie de Parkinson · Cancer Ralentissement de la progression Publication PubMed Voir la publication source Hepatocellular carcinoma (HCC) imposes a substantial health burden in China. Finotonlimab plus bevacizumab recently pro… Human vaccines & immunotherapeutics 2026-08-16 13:06:00 Source
Single-cell transcriptome-guided biomimetic magnetothermal hydrogel m… Bevacizumab · PMID 42569466 Cancer Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Incomplete resection and rapid postoperative recurrence remain major challenges in glioblastoma (GBM) treatment. Inspir… Bioactive materials 2026-08-16 13:06:00 Source
Resolving spectral overlaps in Anti-Parkinson drug combinations: a gr… Stalevo · PMID 41917978 Maladie de Parkinson Thérapie génique Publication PubMed Voir la publication source A selective and eco-friendly spectrophotometric approach was developed for the quantitative determination of entacapone… BMC chemistry 2026-08-16 13:05:56 Source
Adenosine A receptor activation in the nucleus accumbens decreases mo… istradefylline · PMID 41085662 Maladie de Parkinson À vérifier Publication PubMed Voir la publication source Wheel running is a highly motivated behavior in rodents and is often used as a natural reinforcer. The adenosine A rece… Psychopharmacology 2026-08-16 13:05:51 Source
A technology framework for distributed preoperative planning and medi… Evaluation of Advanced Imaging and Visualization for Clinical Deep Brain Stimulation · PMID 40… Maladie de Parkinson À vérifier Publication PubMed Voir la publication source Deep brain stimulation (DBS) is a groundbreaking therapy for movement disorders, necessitating precise planning and ext… Computerized medical imaging and graphics : the offici… 2026-08-16 13:05:48 Source
Changes in anxiety, quality of life, and functioning following psiloc… Psilocybin · PMID 42248535 Maladie d’Alzheimer · Cancer · Migraine · Maladie de Parkinson · Sclé… Traitement symptomatique Publication PubMed Voir la publication source Psilocybin has demonstrated promise for improving depressive symptoms in treatment-resistant depression, but its effect… Journal of affective disorders 2026-08-16 13:05:38 Source
Prescribing and monitoring of riluzole in amyotrophic lateral scleros… Riluzole · PMID 42594365 Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source This retrospective cohort study assessed adherence to the Motor Neurone Disease New Zealand best practice guidelines an… The New Zealand medical journal 2026-08-16 13:05:38 Source
Psychedelics and autism spectrum disorder: Mechanistic insights, tran… Psilocybin · PMID 42385294 Maladie d’Alzheimer · Cancer · Migraine · Maladie de Parkinson · Sclé… Traitement symptomatique Publication PubMed Voir la publication source Autism spectrum disorder (ASD) is a heterogeneous neurodevelopmental condition characterized by persistent deficits in… Journal of psychiatric research 2026-08-16 13:05:38 Source
Pupil-DLC: An open-source deep learning pipeline for scalable, marker… Psilocybin · PMID 42401399 Maladie d’Alzheimer · Cancer · Migraine · Maladie de Parkinson · Sclé… À vérifier Publication PubMed Voir la publication source Pupil diameter is a non-invasive biomarker of brain state, correlating with arousal, attention, cognitive processing, a… Journal of neuroscience methods 2026-08-16 13:05:38 Source
A phytotherapeutic candidate for neuropathic pain: Helicteres ovata (… paclitaxel · PMID 42532226 Cancer · Maladie de Parkinson · Maladie de Parkinson · Cancer Immunomodulation · Traitement symptomatique Publication PubMed Voir la publication source Helicteres ovata is a native Brazilian species belonging to a genus traditionally used for the treatment of inflammator… Journal of ethnopharmacology 2026-08-16 13:05:37 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.